Endpoint definition
↥| Name | RX_ASTMA_BIOL |
|---|---|
| Long name | Biological medicines for asthma |
| Medicine purchases: ATC codes | R03DX05|R03DX08|R03DX09|R03DX10|D11AH05 |
| First defined in version | DF5 |
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 10 | 7 | - |
| Unadjusted prevalence (%) | 0.00 | 0.01 | - |
| Mean age at first event (years) | 62.92 | 67.27 | - |
| Case fatality at 5-years (%) | 0.00 | 0.00 | - |
Longitudinal metrics
| All | Female | Male | |
|---|---|---|---|
| Median nb. of events per indiv. | 2.5 | 2.0 | - |
| Recurrence at 6 months (%) | 58.33 | 50.00 | - |
Survival analyses between endpoints
↥Plot
before Biological medicines for asthma
after Biological medicines for asthma
Loading survival analyses plot…
Table
Loading survival analyses table…